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Objective: This study determined neurodevelopmental outcomes of survivors of neonatal cardiac surgery for
interrupted aortic arch through an interprovincial program and explored preoperative, intraoperative, and postop-
erative outcome predictors.
Methods: Children who underwent neonatal cardiac surgery for interrupted aortic arch at 6 weeks old or younger
between 1996 and 2006 had a multidisciplinary neurodevelopmental assessment at 18 to 24 months old (mental
and psychomotor developmental indices as mean  SD and delay [score<70]). Survivor outcomes were com-
pared by univariate and multivariate analyses and compared between children with and without chromosomal
abnormality.
Results:Outcomes were available for all 26 survivors (mortality, 3.7%). Mental and psychomotor developmental
indices were 75.8  17.1 and 72.3  16.9, respectively, with significantly lower scores for children with chro-
mosomal abnormalities, which accounted for 29% of the variance in developmental indices. For the remaining 17
children without chromosomal abnormalities, mental and psychomotor developmental indices were 82.7  14.5
and 79.1  14.3, respectively, with deep hypothermic circulatory arrest time and Apgar score at 5 minutes con-
tributing 46% of the variance in mental developmental index.
Conclusions: The neurodevelopmental indices of children who have undergone neonatal cardiac surgery for in-
terrupted aortic arch are below normative values; those of children with chromosomal abnormalities are even
lower. For children without a chromosomal abnormality, longer deep hypothermic circulatory arrest times and
low Apgar scores predict lower mental developmental indices at 18 to 24 months of age.
Congenital Heart Disease Joynt et alThe congenital heart defect, interrupted aortic arch (IAA),
occurs in an estimated 2 per 100,000 births and accounts
for 1.5% of all congenital heart disease.1 It comprises either
a complete discontinuity or nonpatent fibrous strand in the
transverse arch or aortic isthmus and can be classified into
distinct types (A, B, and C).1,2 IAA can cause significant
morbidity or death before or after surgery. The medical and
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doi:10.1016/j.jtcvs.2009.03.016924 The Journal of Thoracic and Cardiovascular Sursurgical management of IAA can be complex; however,
overallmortality has improved during the last fewdecades.2,3
As with other complex congenital heart lesions, many risk
factors before, during, and after surgical repair contribute to
outcomes. Previous literature on IAA surgery has focused
mainly on mortality and surgical reintervention as the
main outcomes of importance.2,3 With increasing survival,
attention has shifted to ongoing health and neurodevelop-
mental outcomes.2,4 If developmental disabilities are found
to be prevalent among children with corrected cardiac con-
ditions, medical services must expand to provide specialized
educational services and family support.
Adverse neurodevelopmental outcomes for infants who un-
dergo complex cardiac surgerymay be related to preoperative,
intraoperative, and postoperative factors.5 Previous studies of
childrenwith congenital heart disease have implicated various
factors as predictors of abnormal neurodevelopment, includ-
ing chromosomal abnormalities, birth weight, preoperative
ventilation time, abnormal results of preoperative neurologi-
cal exam, and durations of cardiopulmonary bypass and
deep hypothermic circulatory arrest (DHCA).6-14
Certain complex congenital heart lesions appear to
increase the risk for lower mental developmental orgery c October 2009
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CI ¼ confidence intervals
DHCA ¼ deep hypothermic circulatory arrest
IAA ¼ interrupted aortic arch
MDI ¼ mental developmental index
PDI ¼ psychomotor developmental index
RLFCP ¼ regional low-flow cerebral perfusion
psychomotor developmental indices, especially in the area
of coordination skills, with the pattern of neurodevelopmen-
tal disability differing by specific congenital cardiac defect.6-
15 Because of the relative infrequency of IAA, there is a
paucity of literature on the neurodevelopmental outcomes
of affected children.
Approximately half of all patients with IAA have a deletion
of a 1.5- to 3-Mb region of chromosome band 22q11.2,
del(22)(q11.2), which is associated with a 45% chance of
mental delay and 79% chance of significant motor delay.16,17
Recent cohort studies have demonstrated that children with
a cardiac condition and del(22)(q11.2) haveworse neurodeve-
lopmental outcomes than do those with matched cardiac con-
ditions. The developmental problems appear to be a function
of del(22)(q11.2) or an interaction between the chromosomal
defect and intracardiac surgery.9,18 To our knowledge, the
neurodevelopmental status of children with IAA without
chromosomal abnormalities has not been determined.
We sought to assess neurodevelopmental outcomes at 18 to
24 months of children who underwent neonatal cardiac
surgery for IAA at 6 weeks of age or younger at Stollery
Children’s Hospital (Edmonton, Alberta, Canada) and to de-
termine the proportion of variability in neurodevelopmental
outcomes explained by preoperative, intraoperative, and post-
operative factors. We hypothesized that the neurodevelop-
mental outcomes would be below normative values, with
preoperative patient variables influencing this result. The iden-
tification of at-risk childrenandmodifiable risk factors for neu-
rodevelopmental disabilitymay allow themedical community
to provide comprehensive parental counseling, to explore
avenues of clinical improvement, and to refer for early inter-
vention to improve long-term outcomes for those affected.
MATERIALS AND METHODS
This descriptive analysis used data from an interprovincial inception co-
hort study conducted across four western Canadian provinces.
Subjects
As previously described, infants requiring neonatal surgery for IAA
at 6 weeks of age or younger at Stollery Children’s Hospital (Edmonton,
Alberta, Canada) from September 1996 to August 2006 were identified
at the time of surgery.7,14 All infants with IAA during this 10-year time
frame, including those with chromosomal abnormalities, were included.
All chromosomal abnormalities were confirmed with either DNA
analysis, fluorescence in situ hybridization with standard probes, micro-The Journal of Thoracic andsatellite analysis of chromosomes, or real-time polymerase chain
reaction.19,20 Children who died in the neonatal or pediatric intensive
care units before cardiac surgery were excluded. No parents declined
participation in the study.
The operations were performed under conditions of DHCA for the arch re-
pair, with a modified pH stat cooling strategy and a target core temperature of
18C. Associated lesions were repaired during the cooling or rewarming
phase. Those aortic arch repairs that included regional low-flow cerebral per-
fusion (RLFCP)were performed at 18C to 20Cwith arterial flows of 50mL/
(kg $ min) through a 3.5-mm polytetrafluoroethylene (GORE-TEX; W. L.
Gore & Associates, Inc, Newark, Del) graft sewn to the innominate artery.
Multidisciplinary neurodevelopmental assessments of the survivors
occurred at previously specified intervals at developmental follow-up
clinics in Edmonton and Calgary, Alberta, Canada; Regina and Saskatoon,
Saskatchewan, Canada; Vancouver, British Columbia, Canada; and Winni-
peg, Manitoba, Canada. Ethics approval was obtained from each site before
study onset, and parents or guardians signed consent.
Medical and Neurodevelopmental Assessments
Medical and neurodevelopmental outcome assessments were completed
at 18 to 24 months of age. A research nurse recorded medication history,
hospitalizations, illnesses, and supplemental oxygen use and also docu-
mented physical measurements as previously described.7,14 The socioeco-
nomic status was determined according to the Blishen Index, and
maternal education was indicated by the years of schooling.21 Each child
was examined by a pediatrician experienced in neurodevelopmental follow-
up for evidence of cerebral palsy or visual impairment, defined as corrected
visual acuity in the better eye of less than 20/60. In a soundproof environ-
ment, experienced audiologists evaluated the children for hearing loss,
defined as binaural sensorineural hearing loss of more than 40 dB at any fre-
quency from 250 to 4000 Hz. Pediatric psychologists and psychometrists
administered the Bayley Scales of Infant Development II, an accepted stan-
dardized outcome measure of mental developmental index (MDI) and psy-
chomotor developmental index (PDI) scores with a mean of 100 and SD of
15.22 Developmental indices of less than 70 (2 SD below the mean, 2.27%
of a normally distributed population) indicated mental or motor delay.
Behavioral indices were also recorded, with scores at or below the 10th
percentile considered nonoptimal.
Demographic, preoperative, intraoperative and postoperative variables
were collected prospectively (Table 1).23 The variables chosen for analysis
were based on the literature for developmental outcomes of children with
congenital heart disease and del(22)(q11.2).6-11,18
The primary outcomes examinedwere the developmental indices ofMDI
and PDI. Secondary outcomes of interest were mortality and morbidity.
Morbidity was defined by health and growth outcome variables (Table 2).
Statistics
Continuous variables are presented as mean  SD and median with in-
terquartile range, and categoric variables are presented as counts and per-
centages. Comparisons between the groups are given as difference in
means or proportions with 95% confidence interval (CI). Neurodevelop-
mental outcomes are shown as mean  SD, delay (>2 SD below mean),
or nonoptimal (10th percentile). To screen for variables associated with
neurodevelopmental outcomes, univariate linear regression or odds ratios
with CIs were used. Multivariable linear regression analysis, with clinically
and literature relevant variables found significant (P< .10) on univariate
analysis, identified variables predicting outcomes (significance level .05).
With stepwise multivariable regression, the percentage of variability in out-
comes explained by the linear relation with predictor variables was calcu-
lated. Children were analyzed as a whole group, and an analysis of
children without chromosomal abnormalities was also performed. Statistical
analysis was performed with SPSS, version 15.0 for Windows (SPSS, Inc,
Chicago, Ill).Cardiovascular Surgery c Volume 138, Number 4 925
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Congenital Heart Disease Joynt et alTABLE 1. Descriptive variables of 26 surviving children with neonatal interrupted aortic arch surgery: Comparison between those with and
without chromosomal abnormality
Chromosomal abnormality
Total (n ¼ 26) No (n ¼ 17) Yes (n ¼ 9) Difference (95% CI)
Preoperative
Socioeconomic status (Blishen Index21)
Mean  SD 40  12 41  13 39  11 1.825 (8.449 to 12.096)
Median and IQR 40 (32–48.5) 40 (32–50) 41 (31.5–43.5)
Mother’s schooling (y)
Mean  SD 12.8  2.8 12.9  2.2 12.4  3.9 0.497 (1.966 to 2.960)
Median and IQR 12.5 (11.8–14.3) 12 (11.5–14.5) 13 (11.5–15.0)
Gestational age (wk)
Mean  SD 39  1.8 39.3  1.5 38.6  2.4 0.739 (0.812 to 2.289)
Median and IQR 39.5 (38.8–40.0) 40 (39–40) 39 (37–40)
Birth weight (g)
Mean  SD 3164  626 3231  697 3036  474 194.7 (342.9 to 732.4)
Median and IQR 3053 (2760–3500) 3051 (2765–34.95) 3139 (2637–3536)
Prenatal diagnosis 1 (3.8%) 1 (5.9%) 0 (0%) 5.88% (20.45 to 23.33)
Apgar score at 5 min<7 4 (15.4%) 2 (11.8%) 2 (22.2%) 10.45% (42.49 to 19.52)
Referral out of region 16 (62.0%) 10 (58.8%) 6 (66.7%) 7.84% (41.81 to 30.33)
Male 16 (61.5%) 10 (58.8%) 6 (66.7%) 7.84% (41.81 to 30.33)
Convulsions 1 (3.8%) 1 (5.9%) 0 (0%) 5.88% (20.45 to 23.33)
Interrupted aortic arch
Type A 8 (30.8%) 7 (41.2%) 1 (11.1%)
Type B 18 (69.2%) 10 (58.8%) 8 (88.9%) 30.06% (55.7 to 7.89)
Associated cardiac lesions
Type A and VSD 2 (7.7%) 2 (11.8%) 0 (0%)
Type B and VSD 13 (50%) 7 (41.2%) 6 (66.6%)
Type B and VSD plus LVOTO 3 (11.5%) 1 (5.9%) 2 (22.2%)
Major noncardiac diagnosis 14 (51.9%) 4 (23.5%) 9 (100%) 76.47% (90.68 to38.50)
Inotropes 10 (38.5%) 6 (35.3%) 4 (44.4%) 9.15% (45.16 to 27.94)
Highest plasma lactate (mmol/L)
Mean  SD 3.9  5.0 5.1  5.9 1.9  0.67 3.192 (0.1054 to 6.281)
Median and IQR 2.2 (1.5–2.9) 2.4 (1.5–6.8) 1.8 (1.4–2.45)
Lowest arterial pH
Mean  SD 7.30  0.064 7.31  0.06 7.29  0.07 0.016 (0.0329 to 0.0714)
Median and IQR 7.31 (7.26–7.36) 7.32 (7.26–7.37) 7.31 (7.27–7.34)
Ventilation used 21 (80.8%) 13 (76.5%) 8 (88.9%) 12.41% (38.32 to 22.05)
Intraoperative
Year of surgery
Mean  SD 2002.4  2.7 2002.4  2.8 2002.6  2.6 0.228 (0.2921 to 0.7470)
Median and IQR 2003.5 (2000.8–2004.2) 2003 (2000–2004.5) 2004 (2001–2004.5)
Age at surgery (d)
Mean  SD 11  9 11  7 12  11 1.000 (8.644 to 6.641)
Median and IQR 9 (5–16.3) 9 (5.5–16.5) 8 (3.5–17)
Weight at surgery (kg)
Mean  SD 3.2  0.6 3.3  0.69 3.07  0.4 0.2841 (0.2148 to 0.7831)
Median and IQR 3.1 (2.8–3.5) 3.1 (2.75–3.6) 3.1 (2.8–3.35)
Cardiopulmonary bypass time (min)
Mean  SD 103.9  40.1 104.9  39.8 99.9  42.8 6.052 (28.67 to 40.78)
Median and IQR 88.5 (73.3–132.5) 102 (72.5–132.0) 85 (69.5–143.5)
Crossclamp time (min)
Mean  SD 63  19.5 65.2  17.6 59.2  23.2 5.954 (10.761 to 22.67)
Median and IQR 59 (48–68.5) 60 (52.5–73.5) 55 (45–67.5)
DHCA time (min)
Mean  SD 31.8  22.4 30.9  22.7 33.3  23.2 2.392 (21.84 to 17.06)
Range and IQR 0–6632 (7.5–50.7) 0–6337 (4–49.5) 0–6627 (12–54)926 The Journal of Thoracic and Cardiovascular Surgery c October 2009
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Chromosomal abnormality
Total (n ¼ 26) No (n ¼ 17) Yes (n ¼ 9) Difference (95% CI)
DHCA used 21 (80.8%) 13 (76.5%) 8 (88.9%) 0.0813 (0.2341 to 0.5987)
Regional low-flow perfusion used 9 (34.6%) 6 (35. 3%) 3 (33.3%) 0.0048 (0.4077 to 0.2989)
Postoperative day 1
Inotropes 24 (92.3%) 17 (100%) 8 (88.9%) 11.11% (11.98 to 37.82)
Highest plasma lactate (mmol/L)
Mean  SD 6.0  2.9 6.5  2.9 5.1  2.5 1.452 (0.9511 to 3.854)
Median and IQR 5.0 (3.9–7.3) 5.4 (4.3–7.9) 4 (3.7–6.0)
Lowest arterial pH
Mean  SD 7.33  0.07 7.31  0.07 7.36  0.06 0.0979 (0.1133 to0.0025)
Median and IQR 7.31 (7.29–7.39) 7.31 (7.27–7.35) 7.37 (7.31–7.41)
Postoperative after day 1
Inotropes 25 (96.2%) 17 (100%) 8 (88.9%) 11.11% (11.98 to 37.82)
Highest plasma lactate (mmol/L)
Mean  SD 2.5  1.4 2.4  1.5 2.7  1.4 0.2843 (1.518 to 0.9497)
Median and IQR 1.9 (1.4–3.2) 1.9 (1.4–3) 2.4 (1.45–4.25)
Lowest arterial pH
Mean  SD 7.34  0.05 7.34  0.051 7.34  0.05 0.0028 (0.0415 to 0.0469)
Median and IQR 7.34 (7.31–7.37) 7.34 (7.32–7.38) 7.35 (7.31–7.37)
All postoperative
Convulsions 2 (8%) 1 (6%) 1 (11.1%) 5.22% (34.29 to 18.98)
Dialysis 1 (4%) 1 (6%) 0 (0%) 5.88% (20.45 to 23.32)
Overall
Ventilation duration (d)
Mean  SD 18.0  28.9 20.8  34.8 12.1  6.03 9.264 (15.914 to 34.44)
Median and IQR 13.0 (7.5–17.5) 12 (9–18) 13 (7.5–14)
Hospital stay (d)
Mean  SD 33.7  39.7 35.8  48.7 28.8  18.1 7.046 (27.94 to 42.03)
Median and IQR 22.5 (15–39.3) 22.0 (15.5–39.5) 28.0 (13.5–40.0)
CI, Confidence interval; IQR, interquartile range; VSD, ventricular septal defect; LVOTO, left ventricular outflow tract obstruction; DHCA, deep hypothermic circulatory arrest.RESULTS
Description of Study Participants
There were 27 neonates with IAA who underwent cardiac
surgery during the study duration. One female patient with
del(22)(q11.2) and type B IAA with a hypoplastic aortic
valve died in the hospital within a month after surgery
done before 2000 (mortality, 3.7%). She had been trans-
ferred from out of region and had lenticulostriate infarctions
on computed tomographic scan, postoperative convulsions,
and persistent pulmonary hypertension.
Of the 26 survivors, 9 had chromosomal abnormalities, in-
cluding del(22)(q11.2) (n¼ 6), 1q21.1 deletion (n¼ 2), and
partial trisomy 13 (n¼ 1). All 26 survivors were assessed in
follow-up. Preoperative, intraoperative, and postoperative
variables, listed in Table 1, demonstrated only two signifi-
cant differences between those children with and without
chromosomal abnormalities. Children with chromosomal
abnormalities had more major noncardiac diagnoses and
lower preoperative plasma lactate levels (P< .05).
Only 1 child had a prenatal diagnosis of IAA. Preoperative
ventilation or inotrope use occurred in 81% and 39% of
neonates, respectively. No infants required preoperative extra-The Journal of Thoracic and Ccorporeal membrane oxygenation or cardiopulmonary resus-
citation. RLFCP was used beginning in 2004. The mean age
at IAA repair was 11 days. All but 1 child had postoperative
inotrope use for longer than 24 hours. Among survivors,
convulsions occurred preoperatively in 1 child without
chromosomal abnormality and postoperatively in 2 children
(1 each with and without chromosomal abnormality).
Health and Growth Outcomes
The health and growth outcomes at 18 to 24 months of age
for the 26 survivors in relation to chromosomal abnormali-
ties are shown in Table 2. The two groups differ significantly
only in respect to the increased number of children with
chromosomal abnormalities who had a height below the
3rd percentile. Four children required surgical reintervention
before 2 years of age; 3 for resection of left ventricular out-
flow tract obstruction and 1 for aortic arch obstruction with
a residual ventricular septal defect.
Neurodevelopmental Outcomes
Neurodevelopmental assessment occurred at 18 to 24
months (mean 20.6  3.5 months; Table 3). There were noardiovascular Surgery c Volume 138, Number 4 927
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Congenital Heart Disease Joynt et alTABLE 2. Health and growth outcomes at 18 to 24 months of 26 survivors after neonatal interrupted aortic arch surgery in relation to
chromosomal abnormality
Chromosomal abnormality
Total (n ¼ 26) No (n ¼ 17) Yes (n ¼ 9) Difference (95% CI)
Height<3d percentile 5 (19.2%) 1 (5.9%) 4 (44.4%) 38.56% (67.42 to2.42)
Weight<3d percentile 5 (19.2%) 2 (11.8%) 3 (33.3%) 21.56% (53.39 to 12.24)
Microcephaly 2 (7.7%) 0 (0%) 2 (22.2%) 22.22% (50.17 to 6.15)
Hospitalizations
Not cardiac related
Mean  SD 1.69  2.3 1.2  2.2 2.6  2.4 1.320 (3.23 to 0.592)
Median and IQR 1 (0–2) 1 (0–2) 2 (2–4.5)
Cardiac related
Mean  SD 0.5  1.1 0.71  1.3 0.11  0.33 0.595 (0.109 to 1.299)
Median and IQR 0 (1–1.0) 0 (0–1) 0.33 (0–0)
Other illnesses requiring doctor’s
care (not check-up)
Mean  SD 4  4.8 2.6  1.9 6.7  7.3 4.078 (9.722 to 1.566)
Median and IQR 2.5 (1–5) 2 (1–3.5) 4 (2–10)
Specialists currently seen, excluding
primary care physicians
Mean  SD 3.1  2.4 2.3  1.3 4.7  3.2 2.417 (4.89 to 0.056)
Median and IQR 3 (1.8–4) 2.2 (1–3) 3 (2–8)
Gastrostomy feeding,
any since discharge
8 (30.8%) 3 (17.6%) 5 (55.6%) 37.90% (68.16 to 1.17)
Long-term pulmonary
medications
6 (23.1%) 3 (17.6%) 3 (33.3%) 15.68% (49.13 to 18.51)
Long-term cardiac
medications
2 (7.7%) 2 (11.7%) 0 (0%) 11.76% (16.91 to 30.30)
CI, Confidence interval; IQR, interquartile range.children with cerebral palsy, visual impairment, or sensorineu-
ral hearing loss among 26 survivors.MeanMDI andPDI scores
for survivorswere 75.8 17.1 (median, 78; range, 49-112) and
72.3 16.9 (median, 75; range, 49-99). Among children with
versus without chromosomal abnormalities, the MDI values
were 62.8  14.4 versus 82.7  14.5 (P ¼ .003), and the
PDI values were 59.4  14.4 versus 79.1  14.3 (P ¼ .003).
Among 11 children with delayed MDI or PDI, 7 had both
PDI and MDI delays. MDI and PDI were highly correlated
(r ¼ 0.73, P< .001). Eighteen percent of children without
chromosomal abnormalities had poor motor quality, as did
the majority (7/9) of children with chromosomal abnormal-
ities (Table 3). There was no correlation between neurodeve-
lopmental outcome and socioeconomic status (Blishen
Index)21 or maternal education. Among all survivors after
IAA repair, those with DHCA use had a MDI of 72.3 
15.9, compared with 90.6  15.2 without DHCA (P ¼
.03). Among survivors without chromosomal abnormality,
the MDI of those with DHCA use was 79.3  12.9, versus
93.8  15.6 without DHCA (P ¼ .08), whereas the MDI
with RLFCP versus without RLFCP was 92.7 12.4 versus
77.3  13.0 (P ¼ .03).
Fromdemographic, preoperative, intraoperative, and post-
operative variables listed in Table 1, variables chosen for
clinical and literature relationship to MDI and PDI were
examined with univariate regression.6-11,18 Variables with928 The Journal of Thoracic and Cardiovascular Sua coefficientP<.1 were included in themain forward regres-
sion analysis to predict MDI and PDI (Tables 4 through 6).
The coefficients for predictors in the final model after
stepwise multiple regression indicated that the presence of
a chromosomal abnormality on average reduced MDI by
18.7 (95% CI, 8.6 to 28.8) and PDI by 19.6 (95% CI, 7.4
to 31.8). For MDI, each 5-minute Apgar score point added
4.7 (95% CI, 1.2 to 8.1), whereas the use of DHCA on aver-
age represented a loss of 13.2 (95%CI, 0.9 to 25.5; Table 5).
Chromosomal abnormality explained 29.1% and 28.6% of
the variability inMDI and PDI, respectively, whereas 5-min-
ute Apgar score and use of DHCA explained an additional
16.1% and 8.1%, respectively, of the MDI variability.
When the multiple regression was repeated for the 17 survi-
vorswithout chromosomal abnormalities, theMDI score was
reduced by 0.35 (95% CI, 0.09 to 0.60) for each minute of
DHCA and increased by 3.7 (95% CI, 0.08 to 7.2) for each
Apgar score point. DHCA time accounted for 32.3% of the
MDI score variance, with 5-minute Apgar score accounting
for a further 13.7%. The 5-minute Apgar score accounted
for 41.9% of PDI variance (Table 6).
DISCUSSION
Previous literature describing the outcomes of infants
with IAA focused on mortality, morbidity, and surgical
reintervention.2,3 We report the neurodevelopmental andrgery c October 2009
Joynt et al Congenital Heart DiseaseTABLE 3. Neurodevelopmental outcomes at 18 to 24 months of 26 survivors after neonatal interrupted aortic arch surgery in relation to
chromosomal abnormality
Chromosomal abnormality
Total (n ¼ 26) No (n ¼ 17) Yes (n ¼ 9) Difference (95% CI)
Motor, visual, or sensorineural hearing impairment 0 0 0 —
Mental delay (<70) 9 (34.6%) 3 (17.6%) 6 (66.7%) 0.49.01% (76.40 to8.75)
Psychomotor delay (<70) 9 (34.6%) 3 (17.6%) 6 (66.7%) 0.49.01% (76.40 to8.75)
Mental developmental index
Mean  SD 75.8  17.1 82.7  14.5 62.8  14.4
Median and IQR 78 (58.5–90.0) 87 (73–92.5) 56 (51–80) 19.928 (32.190 to7.666)
Psychomotor developmental index
Mean  SD 72.3  16.9 79.1  14.3 59.4  14.4
Median and IQR 72.3 (52.5–86.0) 79 (73–89) 51 (49–74) 19.614 (31.81 to7.419)
Behavioral index score 10th percentile
Orientation/engagement 2 (7.7%) 0 (0%) 2 (22.2%) 22.22% (50.17 to 6.15)
Emotional regulation 3 (11.5%) 1 (5.9%) 2 (22.2%) 16.33% (46.46 to 12.97)
Motor quality 10 (38.5%) 3 (17.6%) 7 (77.8%) 60.13% (83.74 to19.6)
Total score 6 (23.1%) 3 (17.6%) 3 (33.3%) 15.68% (49.13 to 18.51)
CI, Confidence interval; IQR, interquartile range.C
H
Dhealth outcomes of a group of children with repaired IAA.
This study, with 100% follow-up, found that the mean
and median MDI and PDI scores for all infants undergoing
neonatal cardiac surgery for IAA at 6 weeks or younger
were below normative values. The scores for children with
both IAA and associated chromosomal abnormalities,
many of which were del(22)(q11.2), were even lower.
The mean MDI and PDI scores for the surviving children
after IAA correction were lower than those found in a study
of all neonates with congenital heart surgery done previ-
ously at our institution (MDI, 84 17; PDI, 80 22); how-
ever, the scores were comparable with those of children who
had chromosomal abnormalities.7 A much lower percentage
of children with chromosomal abnormalities (15%) may
have contributed to the higher overall MDI and PDI values
in the previous study. The neurodevelopmental outcomes
were notably lower than those of other postoperative cohorts
of children studied by our interprovincial program after bi-
ventricular repair, such as those with transposition of the
great arteries (MDI, 89  17; PDI, 92  15) or total anom-
alous pulmonary venous drainage (MDI, 87 16; PDI, 89
13).14,24 Shorter mean DHCA times (48% with DHCA for
a mean of 17 minutes with transposition of the great arteries
and 100% with DHCA for a mean of 27 minutes with total
anomalous pulmonary venous drainage) were also seen in
these populations.
The recent study by Gaynor and colleagues6 looking at
two-ventricle cardiac defects also reported higher overall
neurodevelopmental indices (MDI, 91  15 and PDI, 85 
15) despite comparable DHCA times (34 minutes) and per-
centages of children with chromosomal abnormalities
(31%). The types and effect of chromosomal abnormalities
on MDI and PDI were not given for comparison in their
study. Not all chromosomal abnormalities cause severe neu-The Journal of Thoracic androdevelopmental delay, for example the 2 children in our
study with a deletion of 1q21.1, which is not known to con-
tribute to developmental delay.20 Because IAA, especially
type B, is often found with del(22)(q11.2), and the develop-
mental quotient of children with cardiac disease and
del(22)(q11.2) is known to be significantly delayed, the
high prevalence of del(22)(q11.2) in our chromosomal
group may have decreased the overall neurodevelopmental
outcome significantly relative to Gaynor and colleagues’
study encompassing a variety of biventricular repairs.9,18
Assessment of children with del(22)(q11.2) revealed that
79% displayed severe motor delays with poor performance
during testing, which may be related to attention difficulties
and learning disabilities.25 This would be consistent with the
severe motor delay, poor quality of motor skills, and low
mental indices found in our chromosomal abnormality
group, 70% of whom were affected by del(22)(q11.2).
One child with del(22)(q11.2) accounting for 10% of the in-
fants with del(22)(q11.2) and IAA died during the initial
hospitalization. This can be compared with 30% mortality
in a comparable population in a recent study of
del(22)(q11.2) and congenital heart disease by Kyburz and
associates.26
For the 17 children without chromosomal abnormality,
predictors of neurodevelopmental outcome were DHCA
time and 5-minute Apgar score. DHCA has previously
been implicated in poor neurodevelopmental outcome,
with a possible linear dose–response effect or a possible
safety threshold.7,10,27 Recently, we changed our technique
for aortic arch repair to include RLFCP at 18C to 20C
with arterial flows of 50 mL/(kg $ min) through a 3.5-mm
GORE-TEX graft sewn to the innominate artery, as de-
scribed by Asou and coworkers,27 thus eliminating or mini-
mizing the use of DHCA. Whether this will result in betterCardiovascular Surgery c Volume 138, Number 4 929
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Congenital Heart Disease Joynt et alTABLE 4. Significant univariate linear regression analysis in relation to developmental indices for survivors after neonatal interrupted aortic
arch repair
All subjects
(n ¼ 26)
Subjects without chromosomal
abnormality (n ¼ 17)
Variable MDI PDI MDI PDI
Chromosomal abnormality
Regression coefficient 19.93 19.61 — —
95% CI 32.2 to7.7 31.8 to7.4 — —
Apgar score at 5 min
Regression coefficient 4.86 4.436 5.932
95% CI 0.220 to 9.502 0.156 to 8.716 2.36 to 9.503
DHCA time (min)
Regression coefficient 0.298 0.387
95% CI 0.594 to0.003 0.669 to0.109
DHCA used
Regression coefficient 18.314
95% CI 34.509 to2.12
Regional low-flow perfusion used
Regression coefficient 15.394
95% CI 1.525 to 29.263
Lowest arterial pH (d 1)
Regression coefficient 109.59 103.19
95% CI 202.12 to17.03 196.06 to10.33
Postoperative convulsions
Regression coefficient 2.547
95% CI 0.121 to 40.372
MDI, Mental developmental index; PDI, psychomotor developmental index; CI, confidence interval; DHCA, deep hypothermic circulatory arrest.neurodevelopmental outcomes is not clear from the litera-
ture. For children with hypoplastic left heart syndrome and
other functional single-ventricle defects, a retrospective
study by Visconti and associates28 and a prospective study
by Goldberg and colleagues13 showed no benefit of RLFCP
relative to DHCA with respect to neurodevelopmental out-
come at 1 year of age. Interestingly, there are multiple sour-
ces of variability in DHCA time (range, 5.7–23 minutes) and
RLFCP arterial flows (range, 18–50 mL/[kg $ min]) among
the studies of Visconti and associates28 Goldberg and col-
leagues13 and our own, with our own study using higher
TABLE 5. Forward stepwisemultiple regression to predictmental and
psychomotor developmental index values for 26 survivors after
neonatal interrupted aortic arch repair
Adjusted
R2
B
(95% confidence interval)
Variables to predict mental
developmental index
Chromosomal abnormality 0.291 18.684 (28.811 to8.556)
Apgar score at 5 min 0.452 4.654 (1.217 to 8.091)
DHCA used 0.533 13.205 (25.493 to0.917)
Variable to predict psychomotor
developmental index
Chromosomal abnormality 0.286 19.614 (31.81 to 7.419)
Constant for mental developmental index 53.38 (95% confidence interval 21.269 to
85.492); constant for psychomotor developmental index 79.059 (95% confidence
interval 71.884 to 86.234). DHCA, Deep hypothermic circulatory arrest.930 The Journal of Thoracic and Cardiovascular Suflows and a shorter DHCA time of 13 minutes. The contribu-
tion of DHCA to neurodevelopmental outcome in children
with a functional single ventricle versus two ventricles, as
in our study, or a ‘‘safe’’ duration of DHCA remains
controversial.29,30
Thirty-six percent of our patients with IAA had a chromo-
somal abnormality. This important patient characteristic has
repeatedly been identified as an important predictor of poor
neurodevelopmental outcome, which is further substantiated
by this study.6,9 The significant contribution of chromo-
somal abnormalities to neurodevelopmental outcome allows
TABLE 6. Forward stepwisemultiple regression to predictmental and
psychomotor developmental index for 17 survivors after neonatal
interrupted aortic arch repair without chromosomal abnormalities
Adjusted
R2
B
(95% confidence interval)
Variables to predict mental
developmental index
DHCA time (min) 0.323 0.345 (0.601 to0.089)
Apgar score at 5 min 0.460 3.656 (0.079 to 7.232)
Variable to predict
psychomotor
developmental index
Apgar score at 5 min 0.419 5.932 (2.360 to 9.503)
Constant for mental developmental index 62.416 (95% confidence interval 29.413 to
95.419); constant for psychomotor developmental index 28.813 (95% confidence
interval1.96 to 59.586). DHCA, Deep hypothermic circulatory arrest.rgery c October 2009
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Joynt et al Congenital Heart Diseasemedical staff to provide more specific counseling for pa-
tients’ families in the presence or absence of this risk factor.
A lower5-minuteApgar scorewas alsoassociatedwithade-
creased neurodevelopmental outcome. A low Apgar score
may indicate neonates with an elevated risk of intrauterine
or intrapartum compromise of cerebral blood flow or hypox-
emia. Although only 1 child had IAA diagnosed prenatally,
early referrals to centers experienced with perinatal manage-
ment of congenital heart disease may improve neurodevelop-
mental outcome. Further training of ultrasonographers to
increase prenatal detection and the use of prenatal Doppler
flows to detect fetal distress may also improve outcome.
In counseling families of infants with IAA, one should
note the mean and median neurodevelopmental indices
are below normative values even among children without
chromosomal abnormalities. Predictors of mental and mo-
tor outcomes do not relate to social variables. This study in-
dicates that nonmodifiable patient characteristics, such as
chromosomal abnormalities, contribute significantly more
to mental developmental indices than do modifiable intrao-
perative variables, such as DHCA use or duration. For the
17 children without a chromosomal abnormality, poten-
tially modifiable predictors of neurodevelopmental delay
were longer DHCA times and lower 5-minute Apgar scores.
In addition to counseling, identification of neurodevelop-
mental issues can facilitate early referral to intervention
programs aimed at providing children and their families
with additional educational support and resources that
may help both to improve neurodevelopmental deficits
and to adapt to them.
We caution that the interpretations that can be drawn from
our conclusions are limited by the constraints of by the ex-
ploratory nature of this study and the large number of vari-
ables selected from previous literature as of possible
significance.6-11,18 This predictive analysis for developmen-
tal outcome indices could potentially be validated by future
analysis of more recent patients with IAA in our program
when they undergo their 18- to 24-months neurodevelop-
mental assessments.
Because of the low incidence of IAA, our 10-year study
yielded for analysis only 26 children who underwent neona-
tal cardiac repair for IAA. We were able to account for
100% of these children at 18 to 24 months. During the
10-year study period, there were significant changes in
care, including decreased DHCA, increased RLFCP use,
and improved preoperative and postoperative care. The rel-
atively large proportion of the variance accounted for DHCA
may be less if these other changes could be adequately con-
sidered. Because of the relative infrequency of this cardiac
defect, further follow-up of children after IAA surgery
may require larger multisite collaborations.
In conclusion, we found that the neurodevelopmental in-
dices of children who had undergone neonatal cardiac sur-
gery for IAA to be below normative values, with those ofThe Journal of Thoracic and Cchildren with chromosomal abnormalities and DHCA use
even lower. Among children without a chromosomal abnor-
mality, longer DHCA time and lower Apgar score were
predictive of neurodevelopmental delay.
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